| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | — | -94.6% |
| R&D Expense | $1.2M | -17.7% | -55.8% |
| SG&A Expense | $2.5M | +5.1% | +22.4% |
| Operating Income | -$3.7M | +4.1% | +21.6% |
| Net Income | -$3.6M | +11.3% | +24.2% |
| EPS (Basic) | -$0.28 | +37.8% | +49.1% |
| EPS (Diluted) | -$0.28 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.1M | +358.3% | +105.4% |
| Current Assets | $25.0M | +278.7% | +67.3% |
| Total Assets | $30.7M | +136.9% | +70.3% |
| Current Liabilities | $21.2M | +10.4% | +61.3% |
| Total Liabilities | $27.9M | +8.5% | +42.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.3M | — | — |
| Capital Expenditures | $179K | — | — |
| Investing Cash Flow | -$179K | — | — |
| Financing Cash Flow | $18.9M | — | — |
| Free Cash Flow | -$11.5M | — | — |
| +37.8% |
| +49.1% |
| $2.9M |
| +122.4% |
| +292.5% |